DLA Piper has advised Arize AI. Goodwin has advised Dynatrace. Dynatrace, Inc. has entered into a definitive agreement to acquire Arize AI, a leading AI observability...
Dynatrace to Acquire Arize AI in $915 Million Cash and Stock Deal
Gilead to Acquire Tubulis in $5 Billion Oncology-Focused Transaction
Covington has advised Gilead Sciences, Inc. CMS and Goodwin Procter have advised Tubulis GmbH. Gilead Sciences, Inc. has entered into a definitive agreement to acquire Tubulis...
Thoma Bravo to Acquire Olo in $2 Billion All-Cash Transaction
Kirkland & Ellis LLP has advised Thoma Bravo on the transaction, and Goodwin Procter LLP has advised Olo Inc. Fried Frank acted as counsel to Goldman...
DoorDash Acquires SevenRooms in $1.2 Billion Deal
Weil, Gotshal & Manges has advised PSG; Goodwin has advised SevenRooms; A&O Shearman has advised DoorDash. PSG has finalized the sale of SevenRooms, a prominent New...
Clearwater Analytics’ $1.5 Billion Acquisition of Enfusion
Kirkland & Ellis advised Clearwater Analytics, Goodwin Procter advised Enfusion, and Dechert advised the Special Committee of Enfusion on the deal. Clearwater Analytics (NYSE: CWAN), a...
Jade Biosciences’ Merger with Aerovate Therapeutics
Gibson, Dunn & Crutcher advised Jade Biosciences on the transaction, and Cooley advised the placement agents; while Goodwin Procter advised Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc....
MBX Biosciences’ $187.7 Million IPO
Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
Orrstown Financial Services’ Merger with Codorus Valley Bancorp
Raymond James & Associates, Inc. acted as financial advisor to Orrstown and delivered a fairness opinion to the Board of Directors of Orrstown. Goodwin Procter LLP...
Pathos AI’s Acquisition of Rain Oncology
Leerink Partners is acting as exclusive financial advisor and Gibson, Dunn & Crutcher LLP is acting as legal counsel to Rain. Goodwin Procter LLP is acting...
York Capital Management’s Partnership with Comprehensive Rehab Consultants
Goodwin Procter advised York Capital Management in its strategic growth investment in Comprehensive Rehab Consultants. William Blair acted as the sell-side investment banking advisor to CRC....
Kyowa Kirin’s $387 Million Acquisition of Orchard Therapeutics
Kyowa Kirin was represented by Goldman Sachs Japan Co., Ltd. as financial advisor and Morrison & Foerster LLP. as legal advisor. Orchard Therapeutics was represented by...
Revolution Medicines’ Acquisition of EQRx
Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...